Biltmore Family Office’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-379,211
Closed -$2.72M 277
2024
Q3
$2.72M Buy
379,211
+681
+0.2% +$4.84K 0.47% 46
2024
Q2
$2.77M Sell
378,530
-2,126
-0.6% -$18.6K 0.51% 38
2024
Q1
$3.81M Sell
380,656
-10,121
-3% -$88.6K 0.75% 22
2023
Q4
$2.74M Buy
390,777
+231,887
+146% +$1.54M 0.56% 32
2023
Q3
$1.26M Buy
158,890
+5,924
+4% +$37.4K 0.29% 59
2023
Q2
$847K Buy
152,966
+6,139
+4% +$33.7K 0.18% 77
2023
Q1
$835K Buy
146,827
+7,510
+5% +$49.7K 0.18% 84
2022
Q4
$974K Sell
139,317
-214,689
-61% -$2.21M 0.2% 71
2022
Q3
$3.15M Buy
354,006
+21,448
+6% +$248K 0.72% 23
2022
Q2
$3.44M Buy
332,558
+113,248
+52% +$1.68M 0.86% 21
2022
Q1
$4.58M Buy
219,310
+66,578
+44% +$1.45M 0.98% 12
2021
Q4
$3.91M Buy
152,732
+58,497
+62% +$1.62M 0.74% 21
2021
Q3
$2.97M Buy
+94,235
New +$3.27M 0.72% 24

Other funds holding MSOS

Biltmore Family Office's MSOS Position: Q4 2024 in Review

Biltmore Family Office sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2024, closing a stake of 379,211 shares — an estimated $2.72M sold.

Biltmore Family Office first reported a position in MSOS in Q3 2021 and held it in 13 quarters. The position peaked at $4.58M in Q1 2022. 178 funds tracked by Wall St. Rank hold MSOS as of Q4 2024.

  • Biltmore Family Office reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2024 after selling out during the quarter.
  • Biltmore Family Office sold 379,211 AdvisorShares Pure US Cannabis ETF shares in Q4 2024, an estimated $2.72M.
  • Biltmore Family Office first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2021 and held it in 13 quarters.
  • Biltmore Family Office's AdvisorShares Pure US Cannabis ETF position peaked at $4.58M in Q1 2022.
  • 178 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2024.

Based on Biltmore Family Office's 13F filing for Q4 2024, filed 12 Feb 2025.